Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: The Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic study

This publication has 21 references indexed in Scilit:

• Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction
  Journal of Cardiac Failure, 2002
• Comparison of Omapatrilat and Enalapril in Patients With Chronic Heart Failure
  Circulation, 2002
• Reverse remodeling in heart failure with intensification of vasodilator therapy
  Clinical Cardiology, 1997
• Early Versus Delayed Angiotensin-Converting Enzyme Inhibition Therapy in Acute Myocardial Infarction
  Circulation, 1997
• Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.
  Circulation, 1994
• Changes in ventricular volume, wall thickness and wall stress during progression of left ventricular dysfunction
  Journal of the American College of Cardiology, 1993
• Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.
  Circulation, 1992
• Enalapril prevents cardiac fibrosis and arrhythmias in hypertensive rats.
  Hypertension, 1991
• Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure
  New England Journal of Medicine, 1991
• Differential long-term intrarenal and neurohormonal effects of captopril and prazosin in patients with chronic congestive heart failure: importance of initial plasma renin activity.
  Circulation, 1986